AMSBIO is a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology products and services. The AMSBIO range includes unique clinical grade products for stem cell and cell therapy applications such as high quality solutions for viral delivery (lentivirus, adenovirus, and adeno-associated virus) in addition to GMP cryopreservation technology.
In addition the company is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion, proliferation, organoid and spheroid culture, regenerative medicine, stem cell research, and mitochondrial toxicity.
AMSBIO stands out with the industry's broadest selection of recombinant ECMs and AOF growth factors ensuring unparalleled productivity and seamless regulatory compliance. Introducing cutting-edge hydrogel matrix products tailored for PDX applications, organoid, spheroid, and pluripotent stem cell culture, such as Extragel—a like-for-like replacement for Matrigel™, Geltrex™, and Cultrex™ Basement Membrane Extract (BME), and MatriMix—a fully-defined alternative to existing options.
